References
- Hemophilia Federation of America (HFA). [cited 2023 Sep 28] https://www.hemophiliafed.org/disease_type/hemophilia-a/#:~:text=Over%201.1%20million%20people%20worldwide,it%20in%20the%20United%20States.
- Perth Blood Institute. World Hemophilia Day. #WHD 2023. Apr 17 2023 [cited 2023 Sep 28]. https://www.pbi.org.au/news/world-haemophlia-day-2023
- Pabinger I, Mamonov V, Windyga J, et al. Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia a undergoing major orthopaedic surgery. Haemophilia. 2021;27(3):e331–e339. doi: 10.1111/hae.14219
- Windyga J, Guillet B, Rugeri L, et al. Continuous infusion of factor VIII and von Willebrand factor in surgery: trials with pdFVIII LFB or pdVWF LFB in patients with bleeding disorders. Thromb Haemost. 2022;122(8):1304–1313. doi: 10.1055/a-1865-6978
- O’Donovan M, Singleton E, Roche S, et al. Single centre, real-world experience of perioperative rFixfc use in adult patients with haemophilia B undergoing major and minor surgery. Haemophilia. 2021;27(6):e690–e697. doi: 10.1111/hae.14426
- Bae JK, Kim KI, Lee SH, et al. Mid-to long-term survival of total knee arthroplasty in hemophilic arthropathy. J Clin Med. 2020;9(10):3247. doi: 10.3390/jcm9103247
- Oyarzun A, Barrientos C, Barahona M, et al. Knee haemophilic arthropathy care in Chile: midterm outcomes and complications after total knee arthroplasty. Haemophilia. 2020;26(4):e179–e186. doi: 10.1111/hae.14004
- Feng B, Wang Y, Dong X, et al. Long-term clinical outcomes following total knee arthroplasty in patients with hemophilic arthropathy: a single-surgeon cohort after a 10- to 17-year follow-up. Chin Med J (Engl). 2023;136(12):1478–1484. doi: 10.1097/CM9.0000000000002677
- Li Z, Feng B, Du Y, et al. Complications of total knee arthroplasty in patients with haemophilia compared with osteoarthritis and rheumatoid arthritis: a 20-year single-surgeon cohort. Haemophilia. 2020;26(5):861–866. doi: 10.1111/hae.14115
- Ono K, Takedani H. Risk of deep venous thrombosis after total knee arthroplasty in patients with haemophilia a. Haemophilia. 2020;26(5):867–872. doi: 10.1111/hae.14095
- Rosas S, Buller LT, Plate J, et al. Total knee arthroplasty among Medicare beneficiaries with hemophilia a and B is associated with increased complications and higher costs. J Knee Surg. 2021;34(4):372–377. doi: 10.1055/s-0039-1696691
- Canbolat N, Dinç T, Koltka K, et al. Comparison of analgesic consumption of hemophilic and non-hemophilic patients in knee arthroplasty. Ulus Travma Acil Cerrahi Derg. 2022;28(11):1616–1621. doi: 10.14744/tjtes.2021.47482
- Kim MS, Kim JH, Kim KI. Risk factors for increased perioperative blood loss during total knee arthroplasty in patients with haemophilia. Haemophilia. 2022;28(3):491–496. doi: 10.1111/hae.14523
- Wang R, Wang Z, Gu Y, et al. Total knee arthroplasty in patients with haemophilic arthropathy is effective and safe according to the outcomes at a mid-term follow-up. J Orthop Traumatol. 2022;23(1):31. doi: 10.1186/s10195-022-00648-5
- Liu Y, Liu YF, Meng HZ, et al. Total knee arthroplasty exhibits satisfactory long-term clinical efficacy in the treatment of hemophilia patients with stiff knees. Front Surg. 2023;9:1014844. doi: 10.3389/fsurg.2022.1014844
- Ono K, Hirose J, Noguchi M, et al. Extension contracture stiff knee in haemophilia: surgical timing and procedure for total knee arthroplasty. Mod Rheumatol. 2023;33(4):851–855. doi: 10.1093/mr/roac067
- Wang S, Li Q, Zhang Z, et al. Ankle arthrodesis for end-stage haemophilic ankle arthropathy using a Ilizarov method. Int Orthop. 2020;44(5):995–1001. doi: 10.1007/s00264-020-04513-0
- Ahn J, Yoo MC, Seo J, et al. Comparison of total ankle arthroplasty and ankle arthrodesis in end-stage hemophilic arthropathy. Foot Ankle Int. 2020;41(8):937–944. doi: 10.1177/1071100720929002
- Mussawy H, Kehrer M, Strahl A, et al. Clinical and patient reported outcome in total ankle replacement compared to ankle fusion in end-stage haemophilic arthropathy. Haemophilia. 2021;27(6):e739–e746. doi: 10.1111/hae.14429
- Bernstein M, Reidler J, Fragomen A, et al. Ankle distraction arthroplasty: indications, technique, and outcomes. J Am Acad Orthop Surg. 2017;25(2):89–99. doi: 10.5435/JAAOS-D-14-00077
- van Bergen EDP, Mastbergen SC, Vogely HC, et al. Ankle joint distraction is a promising alternative treatment for patients with severe haemophilic ankle arthropathy. Haemophilia. 2022;28(6):1044–1053. doi: 10.1111/hae.14633
- Cai G, Song L, Chen G, et al. Short-term effectiveness of a modified osteotomy for total elbow joint replacement in patients of hemophilic elbow arthritis with severe flexion contracture deformity: a three-cases series report. Orthop Surg. 2022;14(10):2741–2749. doi: 10.1111/os.13457
- He BJ, Mao Q, Li J, et al. Bilateral synchronous total hip arthroplasty for end-stage arthropathy in hemophilia a patients: a retrospective study. Medicine (Baltimore). 2022;101(27):e29667. doi: 10.1097/MD.0000000000029667
- Yao YF, Gao Q, Li JL, et al. Outcome of surgical management of hemophilic pseudotumor: review of 10 cases from single-center. Orthop Surg. 2022;14(1):27–34. doi: 10.1111/os.13174
- Li Z, Xiao K, Chang X, et al. A novel surgical classification for extremity and pelvic hemophilic pseudotumors: the PUMCH classification. J Bone Joint Surg Am. 2023;105(8):630–637. doi: 10.2106/JBJS.22.00781
- Rhoades R, French Z, Yang A, et al. Perioperative outcomes of patients with bleeding disorders undergoing major surgery at an academic hemophilia treatment center. Clin Appl Thromb Hemost. 2023;29:10760296231165056. doi: 10.1177/10760296231165056
- Castaman G, Linari S, Pieri L, et al. Safe and successful surgical outcome in persons with hemophilia a with and without inhibitors treated with emicizumab: a large, single center, real-world experience. J Clin Med. 2023;12(6):2317. doi: 10.3390/jcm12062317
- Carulli C, Innocenti M, Linari S, et al. Joint replacement for the management of haemophilic arthropathy in patients with inhibitors: a long-term experience at a single Haemophilia centre. Haemophilia. 2021;27(1):e93–e101. doi: 10.1111/hae.14169
- Kleiboer B, Layer MA, Cafuir LA, et al. Postoperative bleeding complications in patients with hemophilia undergoing major orthopedic surgery: a prospective multicenter observational study. J Thromb Haemost. 2022;20(4):857–865. doi: 10.1111/jth.15654
- Yuan S, Song L, Jiang H, et al. Perioperative blood loss during joint replacement: comparison between patients with and without hemophilia. J Orthop Surg Res. 2022;17(1):324. doi: 10.1186/s13018-022-03217-y
- Kocaoğlu H, Hennes F, Abdelaziz H, et al. Do patients with von Willebrand disease exhibit higher blood loss and revision rates in hip and knee arthroplasty? A case-control study. Haemophilia. 2020;26(3):513–519. doi: 10.1111/hae.13962
- Feng B, Li Z, Feng C, et al. Early wound complications after orthopaedic surgery for haemophilia: what can we do more. Haemophilia. 2020;26(5):882–890. doi: 10.1111/hae.14113
- Verstraete G, Lambert C, Hammer F, et al. Low rate of subclinical venous thrombosis in patients with haemophilia undergoing major orthopaedic surgery in the absence of pharmacological thromboprophylaxis. Haemophilia. 2020;26(6):1064–1071. doi: 10.1111/hae.14161
- Xu Y, Feng B, Zhu W, et al. Risk factors for amputation in the surgical treatment of hemophilic osteoarthropathy: a 20-year single-center report. Pain Res Manag. 2022;2022:1–10. doi: 10.1155/2022/1512616
- Feng B, Zhu W, Gao P, et al. Orthopedic treatment of musculoskeletal disorders in hemophilic patients. Zhonghua Xue Ye Xue Za Zhi. 2020;41(11):903–907. doi: 10.3760/cma.j.issn.0253-2727.2020.11.004
- Peng HM, Jiang C, Zheng ZB, et al. A retrospective, long-term follow-up of the clinical outcomes and cost-effectiveness of single-anesthetic multiple total joint procedures in hemophilic arthropathy. Orthop Surg. 2023;15(6):1670–1676. doi: 10.1111/os.13743